Aligos Therapeutics (ALGS) Earnings Date & Reports

Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ALGS is expected to report earnings to fall 54.78% to -99 cents per share on August 06

Aligos Therapeutics ALGS Stock Earnings Reports

Q2'26

Est.

$-1.00

Q1'26

Beat

by $1.08

Q4'25

Missed

by $1.66

Q3'25

Missed

by $2.79

Q2'25

Missed

by $1.29

The last earnings report on May 07 showed earnings per share of -221 cents, beating the estimate of -328 cents. With 29.32K shares outstanding, the current market capitalization sits at 26.18M.

View a ticker or compare two or three

ALGS

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days